My understanding is ....
That the as yet unproven technologies will be developed in ADRN, while GERS markets and administers the proven technologies, like COES.
Nothing untowards about that, but it does add a lot of extra legal and accounting work, compared to keeping it all in the same company.
I am not a licensed broker, financial advisor, or IRP. My posts should be considered as "food for thought" and/or "community discussion" only. None of my posts should be construed as investment advice and/or an offer to buy/sell securities. Both the f